IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 96

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: An overview on ocular drug delivery system
Authors Name: Aminu Musa Wada , Shehu Yusuf
Download E-Certificate: Download
Author Reg. ID:
IJNRD_186359
Published Paper Id: IJNRD2309343
Published In: Volume 8 Issue 9, September-2023
DOI:
Abstract: ABSTRACT Ocular medication delivery is the main issue facing pharmacologists and formulation scientists today. The easiest and most widely used kind of treatment is a topical eye drop. Route of drug administration, particularly when treating disorders of the anterior region. Various precorneal, dynamic, and static ocular barriers prevent medication delivery to the targeted ocular tissues. Additionally, target tissues do not retain therapeutic medication levels for an extended period of time. The ocular preparations consist of sterile, buffered, isotonic solutions. They are employed for quick action. They are unable to hold on for an extended period. The fundamental problem with traditional ocular dose forms is that they cannot keep a therapeutic level. Ophthalmic preparations must be devoid of irritants and their physiological properties must not interfere with the eye's normal functioning or cause blurred vision of any kind. The development of innovative, secure, and patient-compliant medication formulations and drug delivery devices/techniques, which may overcome these obstacles and sustain drug levels in tissues, has increased over the past two decades in the field of ocular drug delivery research. Among the various nanoparticles currently available, lipid-based nanosystems have demonstrated increased efficiency and feasibility in topical formulations, making them an important target for ongoing and thorough research in both preclinical and clinical practice. There are numerous new drug delivery systems available for use in the eye. The current review aims to summarize the existing traditional formulations for ocular distribution and their developments, followed by the most recent innovations in formulations based on nanotechnology. Problems associated with traditional ophthalmic dosage forms may be alleviated by the new drug delivery system. Also highlighted are recent advancements in various ocular drug delivery techniques using in situ gels, implants, contact lenses, and micro needles.
Keywords: Key words: ocular drug delivery, nanoparticles, nanotechnology, bioavailability
Cite Article: "An overview on ocular drug delivery system ", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 9, page no.d301-d319, September-2023, Available :http://www.ijnrd.org/papers/IJNRD2309343.pdf
Downloads: 000118759
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2309343
Registration ID: 186359
Published In: Volume 8 Issue 9, September-2023
DOI (Digital Object Identifier):
Page No: d301-d319
Country: Achrol , Rajasthan , India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2309343
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2309343
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD